Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (5176)
Hepion Pharmaceuticals, Inc. (HEPA)
LoPriore Vincent S — Director
Shares
1,250,000
Price
$0.04
Total Value
$50.00K
Shares Held After
6,250,000
% of Holdings
20.0%
Hepion Pharmaceuticals, Inc. (HEPA)
Stetz Gary S. — Director
Shares
1,250,000
Price
$0.04
Total Value
$50.00K
Shares Held After
1,250,000
% of Holdings
100.0%
Hepion Pharmaceuticals, Inc. (HEPA)
LoPriore Vincent S — Director
Shares
5,000,000
Price
$0.04
Total Value
$200.00K
Shares Held After
5,000,000
% of Holdings
100.0%
PHIBRO ANIMAL HEALTH CORP (PAHC)
BENDHEIM JACK — Director
Shares
5,415
Price
$56.17
Total Value
$304.14K
Shares Held After
109,960
% of Holdings
4.7%
PHIBRO ANIMAL HEALTH CORP (PAHC)
BENDHEIM JACK — Director
Shares
1,625
Price
$55.35
Total Value
$89.94K
Shares Held After
115,375
% of Holdings
1.4%
Prelude Therapeutics Inc (PRLD)
Bonita David P — Director
Shares
1,126,126
Price
$4.44
Total Value
$5.00M
Shares Held After
1,126,126
% of Holdings
100.0%
Prelude Therapeutics Inc (PRLD)
Bonita David P — Director
Shares
1,689,189
Price
$4.44
Total Value
$7.50M
Shares Held After
11,808,945
% of Holdings
14.3%
Prelude Therapeutics Inc (PRLD)
ORBIMED ADVISORS LLC — Director
Shares
1,126,126
Price
$4.44
Total Value
$5.00M
Shares Held After
1,126,126
% of Holdings
100.0%
Prelude Therapeutics Inc (PRLD)
ORBIMED ADVISORS LLC — Director
Shares
1,689,189
Price
$4.44
Total Value
$7.50M
Shares Held After
11,808,945
% of Holdings
14.3%
JOINT Corp (JYNT)
JOBSON CHARLES E — 10% Owner
Shares
509
Price
$8.58
Total Value
$4.37K
Shares Held After
1,645,803
% of Holdings
0.0%
PTC THERAPEUTICS, INC. (PTCT)
Klein Matthew B. — Director
Shares
2,850
Price
$70.91
Total Value
$202.09K
Shares Held After
394,070
% of Holdings
0.7%
Twist Bioscience Corp (TWST)
Leproust Emily M. — Director
Shares
1,610
Price
$65.01
Total Value
$104.67K
Shares Held After
858,887
% of Holdings
0.2%
SANGAMO THERAPEUTICS, INC (SGMO)
Dubois-Stringfellow Nathalie — SVP-CHIEF DEVELOPMENT OFFICER
Shares
345,942
Price
$0.26
Total Value
$89.18K
Shares Held After
332,769
% of Holdings
51.0%
Dyne Therapeutics, Inc. (DYN)
Kersten Dirk — Director
Shares
8,300
Price
$20.01
Total Value
$166.12K
Shares Held After
4,199,225
% of Holdings
0.2%
Allogene Therapeutics, Inc. (ALLO)
Yoshiyama Annie — SVP, Finance
Shares
9,586
Price
$2.31
Total Value
$22.14K
Shares Held After
124,517
% of Holdings
7.1%
Dogecoin Cash, Inc. (CBDS)
TOBIAS DAVID — Director
Shares
200,000
Price
$0.01
Total Value
$2.70K
Shares Held After
25,093,000
% of Holdings
0.8%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
278
Price
$25.10
Total Value
$6.98K
Shares Held After
2,502
% of Holdings
10.0%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
278
Price
$25.10
Total Value
$6.98K
Shares Held After
2,502
% of Holdings
10.0%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
278
Price
$25.10
Total Value
$6.98K
Shares Held After
2,502
% of Holdings
10.0%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
278
Price
$25.10
Total Value
$6.98K
Shares Held After
2,502
% of Holdings
10.0%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
1,153
Price
$25.10
Total Value
$28.94K
Shares Held After
40,367
% of Holdings
2.8%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
1,357
Price
$25.10
Total Value
$34.06K
Shares Held After
47,495
% of Holdings
2.8%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
550
Price
$25.10
Total Value
$13.80K
Shares Held After
21,479
% of Holdings
2.5%
LifeStance Health Group, Inc. (LFST)
Bessler Robert — Director
Shares
2,550
Price
$7.01
Total Value
$17.88K
Shares Held After
1,426,196
% of Holdings
0.2%
LifeStance Health Group, Inc. (LFST)
Bessler Robert — Director
Shares
2,551
Price
$7.01
Total Value
$17.88K
Shares Held After
1,309,397
% of Holdings
0.2%
Aditxt, Inc. (ADTX)
HRT FINANCIAL LP — 10% Owner
Shares
72,912
Price
$0.33
Total Value
$24.06K
Shares Held After
133,574
% of Holdings
54.6%
Pacira BioSciences, Inc. (PCRX)
Cross Shawn — Chief Financial Officer
Shares
2,845
Price
$25.01
Total Value
$71.15K
Shares Held After
105,341
% of Holdings
2.6%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
605
Price
$20.05
Total Value
$12.13K
Shares Held After
1,345,367
% of Holdings
0.0%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
15
Price
$20.05
Total Value
$300.75
Shares Held After
13,148
% of Holdings
0.1%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
1,530
Price
$20.05
Total Value
$30.68K
Shares Held After
5,411,121
% of Holdings
0.0%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
769
Price
$20.05
Total Value
$15.42K
Shares Held After
1,814,483
% of Holdings
0.0%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
56,228
Price
$19.51
Total Value
$1.10M
Shares Held After
1,345,972
% of Holdings
4.0%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
1,398
Price
$19.51
Total Value
$27.27K
Shares Held After
13,163
% of Holdings
9.6%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
142,253
Price
$19.51
Total Value
$2.78M
Shares Held After
5,412,651
% of Holdings
2.6%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
71,499
Price
$19.51
Total Value
$1.39M
Shares Held After
1,815,252
% of Holdings
3.8%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
61,345
Price
$6.14
Total Value
$376.66K
Shares Held After
297,066
% of Holdings
17.1%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
400
Price
$1.23
Total Value
$492.00
Shares Held After
275,766
% of Holdings
0.1%
Quantum-Si Inc (QSI)
Keyes Jeffry R. — Chief Financial Officer
Shares
37,381
Price
$0.99
Total Value
$37.19K
Shares Held After
1,732,582
% of Holdings
2.1%
Tilray Brands, Inc. (TLRY)
Hopkinson David G. — Director
Shares
33,556
Price
$6.94
Total Value
$232.88K
Shares Held After
0
% of Holdings
100.0%
Bicara Therapeutics Inc. (BCAX)
Hyep Ivan — Chief Financial Officer
Shares
9,200
Price
$23.00
Total Value
$211.61K
Shares Held After
145,355
% of Holdings
6.0%
Quantum-Si Inc (QSI)
Hawkins Jeffrey Alan — Director
Shares
83,712
Price
$0.99
Total Value
$83.29K
Shares Held After
3,692,423
% of Holdings
2.2%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
214
Price
$167.34
Total Value
$35.81K
Shares Held After
11,666
% of Holdings
1.8%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
312
Price
$166.49
Total Value
$51.94K
Shares Held After
11,880
% of Holdings
2.6%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
332
Price
$165.49
Total Value
$54.94K
Shares Held After
12,192
% of Holdings
2.7%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
78
Price
$164.60
Total Value
$12.84K
Shares Held After
12,524
% of Holdings
0.6%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
64
Price
$163.49
Total Value
$10.46K
Shares Held After
12,602
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
663
Price
$575.72
Total Value
$381.70K
Shares Held After
40,513
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
701
Price
$574.91
Total Value
$403.01K
Shares Held After
41,176
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,366
Price
$573.48
Total Value
$783.37K
Shares Held After
41,877
% of Holdings
3.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
410
Price
$572.48
Total Value
$234.72K
Shares Held After
43,243
% of Holdings
0.9%
Showing 3651–3700 of 5176 transactions (page 74 of 104)